Luminist Labs
Diagnostic platform for early detection of liver disease
Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.
Active Founders
Storm Stillman, CEO
Co-founder and CEO of Luminist Labs (Acquired by DiscernDx) Currently COO @ Curebase (S18)
